However, the group with more than 7 CD56+ CTC/ml at diagnosis was enriched in patients with ES-SCLC (85.7% vs. 52.7%), without reaching statistical significance (Fisher's exact test; p = 0.067). This evidence concerns the gene NCAM1 and small cell lung carcinoma.